摩根基金 - 基因治療主題基金 - JPM基因治療主題(美元) - A股(累計)
97.11美元0.71(0.74%)
2024/12/06更新
績效 / 1月3.58%
3月4.5%
1年3.35%
晨星評等-
- 1.現金0.17%
- 2.股票25.01%
- 3.債券0.00%
- 4.其他74.82%
- 1.美國74.82%
- 2.歐洲不包含歐元區8.19%
- 3.日本6.13%
- 4.歐元區4.44%
- 5.大洋洲2.12%
- 1.Gilead Sciences Inc3.76%
- 2.Alnylam Pharmaceuticals Inc3.56%
- 3.Novartis AG Registered Shares3.26%
- 4.Vertex Pharmaceuticals Inc3.19%
- 5.Bio-Techne Corp3.11%
- 6.Amgen Inc3.02%
- 7.Arcellx Inc2.89%
- 8.Lonza Group Ltd2.89%
- 9.Krystal Biotech Inc2.82%
- 10.Astellas Pharma Inc2.81%
- 1.現金0.17%
- 2.股票25.01%
- 3.債券0.00%
- 4.其他74.82%
- 1.美國74.82%
- 2.歐洲不包含歐元區8.19%
- 3.日本6.13%
- 4.歐元區4.44%
- 5.大洋洲2.12%
- 1.Gilead Sciences Inc3.76%
- 2.Alnylam Pharmaceuticals Inc3.56%
- 3.Novartis AG Registered Shares3.26%
- 4.Vertex Pharmaceuticals Inc3.19%
- 5.Bio-Techne Corp3.11%
- 6.Amgen Inc3.02%
- 7.Arcellx Inc2.89%
- 8.Lonza Group Ltd2.89%
- 9.Krystal Biotech Inc2.82%
- 10.Astellas Pharma Inc2.81%